The manufacturing shift will see Montrose manufacture the chemical compound betamethasone, a potent steroid used in creams to relieve skin irritation, such as itching and flaking from eczema.
Asked about the logic of this move, Mr Witty said: “It’s an absolute reversal of what has become standard practice.
“A few years ago, if you had said you were moving manufacturing processes from India to Scotland, no one would have believed it.
“Payroll is not the issue. Actually, our payroll in Montrose is double the payroll in India.
Friday, April 08, 2011
GSK reveals job plan to swap India for Scotland! Glaxo chief explains move to Scotland - Herald Scotland | Business | Corporate & SME
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment